Li Zhou

Li Zhou currently serves as Associate Director of Regulatory CMC at AbbVie, overseeing global regulatory efforts for biologics development and registration since March 2023. Previously, Li Zhou worked at Taylor & Francis Group as Assistant Editor and a member of the Editorial Board for mAbs from July 2019 to January 2025. Prior experience at AbbVie includes roles such as Principal Research Scientist in Analytical Development and Senior Scientist in various capacities focused on biologics and drug discovery between January 2017 and October 2018.